Data linking and integration for health applications by Maeder, Anthony
1eResearch Australasia, Brisbane, 27 June 2007
Data Linking and Integration
for Health Applications
Dr Anthony Maeder
Research Director
E-Health Research Centre / CSIRO ICT Centre
Brisbane, Queensland, Australia
http://ict.csiro.au/
Overview
 E-Health and Health Data 
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E-Health and Health Data 
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Scope of e-Health
 Contemporary health care has adopted evidence-based 
medicine delivered by multi-disciplinary, multi-party 
health care teams in a patient-centred approach 
 e-Health encompasses the broad application of 
Information and Communication Technologies, in 
support of health care needs
 The main e-Health domains of activity are: 
• Health Information Systems (data and software tools)
• Health Services Delivery (work practices and processes)
3http://ict.csiro.au/
Australian Health Systems Scene
 State-based systems, with different structures for 
management of hospitals and community health
 National and local organisation of private providers
 Australian Government provides financial resource
 Many independent legacy software systems: 
specialised, non-interoperable, unsupported
 Safety, Quality and Efficiency issues driving reform 
of work practices and wider sharing of information
 Key problem is lack of universal health identifier: 
National e-Health Transition Authority aims at this
http://ict.csiro.au/
Need and Benefits of Data Linking
 Currently patient data resides across numerous different 
databases which are unconnected and owned separately
 Different information systems and reporting systems
 Government vs Hospital vs GP vs Allied health systems
 Health care improvement opportunities flow from linking this data
 higher levels of patient care due to fuller information
 extension of evidence-based practice
 better planning or decision making for specific cases
 improvements to training and education, safety and quality
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Privacy Issues
 National Privacy Principles
 Use of health data for treatment purposes
 Secondary use of data for research purposes
 State Acts related to Health Data:
 Health Records and Information Privacy Act (2002) - NSW
 Health Records Act (2001) – Victoria
 Many others
 Organisation principles
 Other policies applicable site by site
 Access to data governed by ethics compliance 
http://ict.csiro.au/
Source: Victorian Privacy Commissioner
Data Linkage and Integration
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Health Data Sources
 National level
 Medicare – cost codes identify 
treatments
 PBS - Pharmaceuticals 
Benefits Scheme  
 State level
 Health department hospital 
admissions data
 State based disease-specific 
data collections 
 Pathology reports & results
 Radiotherapy reports
 Radiology reports & images
 Registries
 Hospital level
 Hospital Information system
 Hospital pharmaceuticals 
database
 Hospital units
 Clinical information systems
 Unit specific data sources
 Clinical areas
 Clinician based data sources
 External sources
 General Practitioners
 Emergency Services
 Allied health enterprises
http://ict.csiro.au/
Data Utilization 
 Data collection management and organisation
 Knowledge discovery (population or cohorts) 
 Understanding and comparison of cases
 Pre-processing and reshaping
 Statistical correlation and analysis
 Data aggregation and integration
 Identify events and trends
 Health awareness and promotion
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Problems to Overcome for Data Linking
 Major practical impediments exist for data linking
 Patient security and privacy restrictions
 Diversity and independence of databases
 Complexity of data formats 
 Sophistication of aggregation methods
 Existing solutions tend to adopt a heavy approach
 Manual processing to achieve one-off linking
 Data repositories or warehousing
 Trusted third party units offering linking services
 Full scale integration and interoperability of all systems
http://ict.csiro.au/
The HDI software tool
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The Health Data Integration Project
 Aims to provide novel methods for linking multiple databases, 
by allowing data custodians to retain control of data
 Processes queries and reporting operations remotely at the 
data locations (in situ)
 Allows privacy and security restrictions to be met
 Enables audit trails of data access operations and users to be 
produced
 Fully software engineered application product has been 
produced at EHRC after about 20 person-years of effort
http://ict.csiro.au/
The HDI Solution
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HDI: Data Custodian Control 
 Data custodian retains control and security
 No warehousing of data
 All patient-identifying data is encrypted
 Databases are added to a HDI installation by the 
data custodian
 The data custodian specifies who can use the data and 
how they can use it
 Metadata layer linked to industry standards to 
provide a common language and across 
repositories – increasing usability
http://ict.csiro.au/
HDI: Delineation of Responsibility
 HDI Domain concept
 Provides demarcation of 
roles and responsibilities
• Domain Administrator
 Supports existing ethics 
committee approval process
• Data Custodian
• Project Administrator
• Project member
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HDI: Building a virtual data collection 
Query on linked CRC 
surgical data and 
chemotherapy data to 
get a dataset of 
information on CRC  
patients, their current 
status and their 
chemotherapy 
treatments.
CRC Surgical 
Data
Chemotherapy 
Record Data
Link Table
Add Search 
Terms
http://ict.csiro.au/
HDI: Building a virtual data collection
Query results show  
CRC surgical data 
and chemotherapy 
data for each 
de-identified patient.
CRC surgical 
data
Chemotherapy 
data
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HDI: Performing an Analysis
 Generate the 
survival chart, for 
example, Kaplan 
Meier.
 Analyse survival 
outcomes by 
stage.
Survival chart
Survival analysis 
statistics
http://ict.csiro.au/
HDI: Generating a report
Data from multiple 
databases can be 
used for reporting.
Eg… linked data 
from surgical 
databases, 
chemotherapy 
records and cancer 
registries  
Report on patients 
given adjuvant 
chemotherapy
Select 
report
Select 
variables on 
which to 
report
Data for 
report
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Current Projects
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Data Linking Projects
Some Current Clinical Applications of HDI
 Queensland Health: Queensland Oncology On Line
 Royal Melbourne Hospital: Colorectal Cancer
 Sydney South West Area Health Services: Colorectal Cancer
 Automated Cancer Staging: Lung Cancer 
12
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Summary of Data Flow
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Makes the data 
accessible
Allows users 
to enter data 
on-line
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Royal Melbourne Hospital: Colorectal Cancer - Overview
 Objective
 Integration of CRC screening, surgery and family history information:
• For research on sensitivity and specificity of the Faecal Occult Blood Test (FOBT)
• For research on surgical outcomes including factors such as adjuvant therapy and  
co-morbidities
 Cohort 
 Surveillance program patient data over 25 years (approx 3000 records)
 Surgical data of approx 4000 records; Family history approx 4000 records
 Databases
 3 databases (CRC Screening Program (administrative and outcomes data), 
Surgical and Clinical CRC data, Family History data)
 Data Quality
 Significant cleaning work required on databases to regularise recorded data 
and remove data entry, data format, or historical information change errors
13
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Royal Melbourne Hospital: Colorectal Cancer - Outcomes
 Data cleaning effort 
and data analysis 
gave access to 25 
years of surveillance 
information
 FOBT sensitivity 
published
 Surgical Outcomes
 By factors such as 
smoking history, 
adjuvant therapy or 
diabetes status
SENSITIVITY OF FAECAL OCCULT BLOOD TESTING (FOBT) FOR 
ASYMPTOMATIC COLORECTAL CANCER AND ADVANCED ADENOMAS 
OVER A 25-YEAR EXPERIENCE IN COLORECTAL CANCER SCREENING
The performance characteristics of FOBT for asymptomatic 
colorectal cancer and advanced adenomas is uncertain. 
Sensitivity, for example, requires direct comparison with a 
gold standard such as colonoscopy or, less accurately, 
close follow-up of a cohort of negative screenees to detect 
interval cancers. 
The Royal Melbourne Hospital Bowel Cancer Surveillance 
Program began in 1979. It coordinates colonoscopic
surveillance (along NHMRC guidelines) and annual FOBT 
of individuals at moderate and high risk of bowel cancer. 
Hemoccult-type FOBT was used  from 1979 to 1986, 
immunochemical testing from 1995 to now, and both test 
types in the interval 1987 to 1994. 
A database of FOBT and colonoscopy results has been 
maintained throughout this time, but the technical resources 
to examine the data have not been available until now.
These results:
• Show that FOBT identifies a sub-group of at-risk but 
asymptomatic people enriched with colorectal 
neoplasia
• Support the need for colonoscopy surveillance in this 
population
• Illustrate the potential of technologically advanced 
database interrogation methods such as MMIM
This study also supports introduction of FOBT-based 
screening for average risk subjects, however, results 
should be interpreted in the light of our population 
being at above-average risk
• 4821 registrants have had 5398 colonoscopies since the 
program started in 1979
• 893 asymptomatic patients with planned colonoscopies 
had a preceding FOBT within 3 months (see Table)
• 5 cancers were detected, with 3 (60%) being FOBT 
positive 
•There were 49 advanced adenomas, of which 17 (34.7%) 
were FOBT positive
• There were 148 episodes with detection of any neoplasia, 
of which 38 (25.7%) were FOBT positive
• Using MMIM, the Surveillance Program database was 
interrogated to identify asymptomatic patients who had a 
scheduled colonoscopy and an FOBT within the preceding 
3 months 
• Patients who had colonoscopy because of a positive FOBT 
or symptoms were not included
• De-identified data was analysed at the EHRC using HDI 
(Health Data Integration) and other tools
• The results of the colonoscopy were characterized as 
normal, carcinoma, advanced adenoma and other 
adenoma
• ‘Advanced adenoma’ was defined as:
• 3 or more polyps
• size >10mm
• villous component or severe dysplasia
• Sensitivity, specificity and predictive value for neoplasia of 
FOBT were calculated according to the efficient-score 
method described by Newcombe
Figure 2 FOBT sensitivity by colonoscopy findings in 
asymptomatic at-risk people
In collaboration with the EHRC (e-Health Research Centre) 
and Bio21MMIM (Molecular Medicine Informatics Model) 
project we reviewed our experience of 25 years of FOBT 
testing in asymptomatic moderate and high risk subjects 
undergoing scheduled colonoscopy, to assess the 
sensitivity, specificity and predictive value for neoplasia of 
FOBT.
Introduction
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Colonoscopy Findings
Normal Other
Adenoma
Advanced 
Adenoma
Carcinoma TOTAL
Negative 645 76 32 2 755
Positive 100 18 17 3 138
Total 745 94 49 5 893
Table  FOBT results by colonoscopy findings in 
asymptomatic at-risk people
Figure 1 The immunochemical FOBT kit in current use
• Specificity for advanced adenomas or cancers was 
85.9 % (95% Confidence Interval, 83.4% - 88.2%)
• The predictive value for a positive FOBT for any 
neoplasia in AS subjects was 27.5% (20.4% to 35.9%)
• The likelihood ratio for detection of an advanced 
adenoma or cancer if the FOBT was positive was 2.6 
(1.8 to 3.9)
Results (cont)
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Colorectal Medicine & Genetics, The Royal Melbourne Hospital1; e-Health Research Centre, CSIRO ICT Centre, Brisbane2; & 
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CRC Services Research Group (NSW) - Overview
 Objective
 Demonstrate the ability to gather patient information across databases and 
across hospitals to provide summary information on quality and safety of 
patient care, adherence to clinical guidelines and comparison across hospitals
 To be able to provide this information to clinicians for access to their own data 
for case management AND for monitoring as above
 Cohort 
 Approx 1000 ‘dummy’ patient records with CRC and corresponding 
administrative and treatment information
 Databases
 Different databases (Registry, Administrative, Surgical, Chemotherapy) for 3 
different hospitals
 Data Quality
 Constructed data included deliberate errors in patient demographics and 
different formats of clinical information to demonstrate HDI’s ability in inexact 
matching and transformation of  data entries to a selected standard
14
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CRC Services Research Group (NSW) - Scenario
Hosp A:
Admin DB
Hosp B:
Admin DB
Hosp C:
Admin DB
Hosp A, 
Surgeon 2:
Procedural 
Records DB
(no chemo data)
Hosp B,
Surgeon 3:
Procedural 
Records DB
(no chemo data)
Hosp C, Surgeon 
4:
Procedural 
Records DB 
(no chemo data)
Hospital B:
Private hospital, not included in Cancer 
Institute NSW Clinical Cancer Registry 
Pilot
Hospital C*:
Non-teaching hospital, not included in 
Cancer Institute NSW Clinical Cancer 
Registry Pilot
Hospital A:
Large teaching hospital, included in 
Cancer Institute NSW Clinical Cancer 
Registry Pilot
Hosp A, 
Surgeon 1:
Procedural 
Records DB
(no chemo data)
Hosp A:
Cancer Institute 
NSW Clinical 
Cancer Registry
Hosp B,
Oncologist 5:
Chemotherapy 
Records DB
AlphaHosp
CINCC
ChemoRec
BudgetHosp CHADMIN
CSurgAccSurgAllSurgery BuddsData
*Hospital C – less CRC 
cases in general, and some 
harder cases referred to 
Hospital A or B. All 
chemotherapy (if required) 
performed by Hospital A or 
B.
Hospital B – All 
chemotherapy (if 
required) 
performed by 
Hospital B.
Hospital A – All 
chemotherapy (if 
required) 
performed by 
Hospital A.
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CRC Services Research Group (NSW) - Outcomes 
 We have 
demonstrated 
that with HDI it is 
possible to report 
on indicators that 
require 
information to be 
linked within and 
across hospitals
%
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Cancer Stage Interpretation System (CSIS)
 Staging of a cancer requires access to all 
available data:
 Radiology and histology text reports
 Information extracted from other forms of data, for 
example, radiological images 
 Cancer Stage Interpretation System (CSIS)
 Cancer staging is necessary to determine effective care 
for individual patients, as well as to design and evaluate 
health programmes at a population level 
 Develop improved ways to access and analyse stored 
medical images and reports to better facilitate the staging 
of cancer patients
http://ict.csiro.au/
Cancer Stage Interpretation System (CSIS)
16
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Future directions
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Clinical to Genomic 
 Integrating biomarker data sources and patient data can provide 
information on the efficacy, safety and toxicity of drugs
• Advanced non small-cell lung cancer - Iressa effective in only 10% to 15% of 
patients. Scientists pinpointed mutations in a gene within some tumor cells that 
allows Iressa to work 
 Advanced breast cancer  - Herceptin issued to 35,000 women world-
wide 1998-2005. Only appears to work for patients whose breast 
cancer cells carry extra copies of the HER2 protein.
 Micro Array experiments may be useful in finding disease biomarkers
• Linking micro array results with known clinical outcomes will allow new 
biomarkers to be found
17
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Figure by Dr Terry O’Brien, Univ Melbourne (1 July 2005)
Bio21 Molecular Medicine Informatics Model (2005)
http://ict.csiro.au/
EHRs and Virtual Registry
 Pre-population of Electronic Health Record
 Use data linking to gather as much information as possible (to required 
health record specification) about an individual to pre-populate their 
complete health record
 Outcomes:
• Reduced manual workload for initial set up of health record
 Virtual registry 
 Use data linking to gather registry data set information about patients 
from existing sources (rather than building brand new sources with 
paper based information submission) – and present back a view of the 
registry for administration and analysis
 Outcomes:
• Significantly reduced manual and paper based workload for clinicians and 
registry officers resulting in more timely registry information, and greater 
compliance with registry requirements if data capture is at source
18
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Contemporary ICT Advances
 Web Services
 Easy(ier) federation of data and services
 Ontologies
 Relating concepts using semantic properties
 Discipline based
• Need domain expertise to define the ontology of data 
sources and fields
 The semantic web
 Using ontologies in the web applications
http://ict.csiro.au/
Using SNOMED CT
 Use SNOMED CT for mapping of data to terms
 Structured data sources
 Natural language
• Reports 
• Discussions
 To make this possible
 Subsets for particular domains
 Augmenting the domain specific subsets
 Fast querying
19
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SNOMED-CT Scope
 Clinical Terms
 Comprehensive, not specialty or domain
 Human, veterinary, drugs, social, disease, observations, 
interventions and wellness
 ~400,000 concepts (fully specified names)
 ~1M descriptions (synonyms etc)
 ~1.4M relationships (900,000 defining)
 URU principles
 Useable, Repeatable, Understandable
http://ict.csiro.au/
SNOMED CT Top-level Concepts
 138875005 | SNOMED CT Concept
 123037004 | body structure |
 404684003 | clinical finding |
 243796009 | context dependent category |
 308916002 | environments and geographical locations |
 272379006 | event |
 106237007 | linkage concept |
 363787002 | observable entity |
 410607006 | organism |
 373873005 | pharmaceutical / biologic product |
 78621006 | physical force |
 260787004 | physical object |
 71388002 | procedure |
 362981000 | qualifier value |
 419891008 | record artifact |
 48176007 | social context |
 370115009 | special concept |
 123038009 | specimen |
 254291000 | staging and scales |
 105590001 | substance |
20
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Expressions, equivalence and subsumption
 85189001|acute appendicitis
 subsumed by
• 74400008|appendicitis|
• 64572001|disease|:
116676008|associated morphology|=23583003|inflamation|
363698007|finding site|=66754008|appendix structure|
 equivalent to
• 74400008|appendicitis|:
260908002|course|=53737009|acute|
http://ict.csiro.au/
Querying
 Simple queries can use subsumption/equivalence, for 
example
 find all cases of 74400008|appendicitis| with a particular 
treatment or outcome
 finding those also classified as
 85189001|acute appendicitis
 or even as a 64572001|disease| with 23583003|inflamation| of 
the 66754008|appendix structure|
21
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